Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor software release. This update does not modify the study data or displayed content on the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a routine site update. No study content or essential functionality was changed.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page shows a new revision number v3.6.3, replacing the previous v3.6.2; this indicates a small backend/documentation update rather than a substantive change to the study details.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a new template/version. This update affects only the page's versioning and does not modify the study details or outcomes.SummaryDifference0.0%

- Check69 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment for this study has ended. This reflects a closure of participant recruitment.SummaryDifference0.4%

- Check77 days agoChange DetectedRevision history updated to v3.5.5, replacing v3.5.4. This indicates an updated edition of the study documents.SummaryDifference0.0%

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.